Skip to content
IP + Technology Law
Home  »  News & Insights  »  Newsletters

Federal Circuit Review | July 2013

July 31, 2013

The Federal Circuit Review is a monthly newsletter featuring the latest case summaries handed down from the U.S. Court of Appeals for the Federal Circuit.

In this Issue:

  • Isolated DNA not Patent Eligible
  • Appeals Before Damages and Willfulness Determination OK
  • Reverse Payment Settlement Agreements May be Invalid 
Federal Circuit Review | July 2013 from Knobbe Martens Olson & Bear | Download PDF

Related Links

News & Insights

Newsletters
Jul 2026
Federal Circuit Review | June 2026
  When ‘Any Patent’ Means No Patent: Federal Circuit Reverses Non-Specific Verdict In Ollnova Technologies Ltd. v. Ecobee Technologies ULC [Opinion], Appeal No. 25-1045, the Federal Circuit held that a...
Publications
Jun 2026
What the USPTO’s New 30-Day Director Review Deadline for Decisions Instituting Trial Means for PTAB Petitioners and Patent Owners
Key Takeaway: In a precedential decision in Light & Wonder, Inc. v. Evolution Malta Ltd., U.S. Patent and Trademark Office Director Squires extended the deadline for requesting Director Review of...
News
Jul 2026
Carol Pitzel Cruz Comments in Law360 on Enablement Analysis in Pharmaceutical Patent Litigation
Knobbe Martens partner Carol Pitzel Cruz was quoted in a recent Law360 article on the Federal Circuit’s decision in Wyeth v. AstraZeneca, a patent infringement dispute centered on Section 112...